IRBESARTAN
These highlights do not include all the information needed to use IRBESARTAN TABLETS safely and effectively. See full prescribing information for IRBESARTAN TABLETS. IRBESARTAN tablets, for oral use Initial U.S. Approval: 1997
068224c4-a34d-32d7-bb2a-7eed44ccf7d3
HUMAN PRESCRIPTION DRUG LABEL
Jun 23, 2022
Jubilant Cadista Pharmacuticals Inc.
DUNS: 118694141
Jubilant Cadista Pharmaceuticals Inc.
DUNS: 022490515
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
IRBESARTAN
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
IRBESARTAN
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
IRBESARTAN
Product Details
FDA regulatory identification and product classification information